A new trading day began on Tuesday, with cbdMD Inc (AMEX: YCBD) stock price up 5.96% from the previous day of trading, before settling in for the closing price of $0.47. YCBD’s price has ranged from $0.42 to $1.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 7.78% over the past five years. Meanwhile, its annual earnings per share averaged 80.26%. With a float of $3.12 million, this company’s outstanding shares have now reached $3.76 million.
Let’s look at the performance matrix of the company that is accounted for 52 employees. In terms of profitability, gross margin is 60.66%, operating margin of -87.94%, and the pretax margin is -94.12%.
cbdMD Inc (YCBD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of cbdMD Inc is 17.01%, while institutional ownership is 2.28%.
cbdMD Inc (YCBD) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.21 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.26% per share during the next fiscal year.
cbdMD Inc (AMEX: YCBD) Trading Performance Indicators
Here are cbdMD Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.88, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -0.89 in one year’s time.
Technical Analysis of cbdMD Inc (YCBD)
cbdMD Inc (AMEX: YCBD) saw its 5-day average volume 0.29 million, a positive change from its year-to-date volume of 0.16 million. As of the previous 9 days, the stock’s Stochastic %D was 36.08%. Additionally, its Average True Range was 0.05.
During the past 100 days, cbdMD Inc’s (YCBD) raw stochastic average was set at 33.06%, which indicates a significant decrease from 52.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.19% in the past 14 days, which was higher than the 66.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4891, while its 200-day Moving Average is $0.6504. Nevertheless, the first resistance level for the watch stands at $0.5346 in the near term. At $0.5712, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6224. If the price goes on to break the first support level at $0.4468, it is likely to go to the next support level at $0.3956. Assuming the price breaks the second support level, the third support level stands at $0.3590.
cbdMD Inc (AMEX: YCBD) Key Stats
With a market capitalization of 1.88 million, the company has a total of 3,763K Shares Outstanding. Currently, annual sales are 24,160 K while annual income is -22,940 K. The company’s previous quarter sales were 5,170 K while its latest quarter income was 460 K.
